Otsuka Holdings Co., Ltd. is a Japan-based healthcare company that oversees the Otsuka Group’s pharmaceutical, nutraceutical and consumer health businesses. The company’s operations are primarily conducted through subsidiaries, including Otsuka Pharmaceutical Co., Ltd., which researches, develops, manufactures and markets prescription medicines, over-the-counter products and health-related foods.
Otsuka’s pharmaceutical activities focus on areas such as psychiatry, oncology, cardiovascular and renal medicine, and several other specialized therapeutic fields. Its nutraceutical and consumer health businesses offer products designed to support hydration, nutrition and general wellness, including the Pocari Sweat and Oronamin C brands in select markets. The group also has activities in medical devices and other health-related businesses.
Otsuka Holdings was established in 2008 as the holding company for the Otsuka Group and was listed on the Tokyo Stock Exchange in 2010. The group serves customers in Japan and international markets through research, manufacturing and commercial operations across North America, Europe, Asia and other regions. Tatsuo Higuchi serves as president and chief executive officer of Otsuka Holdings.
AI Generated. May Contain Errors.
